Thursday, November 19, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
News articleYahoo Finance· July 23, 2026

Novocure Reports Second Quarter 2026 Financial Results

View original at finance.yahoo.com
Novocure Reports Second Quarter 2026 Financial Results Quarterly net revenues of $184 million, an increase of 16% year-over-year, driven by 18% global active patient growth across indications CE Mark received for Optune Pax® for the treatment of locally advanced pancreatic cancer, Germany first market to launch in EU M…
Opening lines of the source · Yahoo Finance · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • This was Novocure's strongest quarter to date, with record net revenues and active patients on therapy; the company continues to launch its therapies in multiple markets and is making material progress on its path to profitability.

    60% confidence

Cited in these Via News reports

Novocure Reports Second Quarter 2026 Financial Results: Source | Via News | ai.via.news